Publications
- Aggressive acute myeloid leukemia in PU.1/p53 double-mutant mice2014 | First Faculty of Medicine
- Characterization of chromosome 11 breakpoints and the areas of deletion and amplification in patients with newly diagnosed acute myeloid leukemia2013 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Notes to the pathophysiology of myelodysplastic syndrome, demethylation therapy and the role of cytokine-induced differentiation2013 | First Faculty of Medicine
- Initial experience of Czech MDS Group with 5-azacytidine in patients with high risk myelodysplastic syndromes (IPSS intermediate II and high), acute myeloid leukaemia with less than 30% myeloblasts and chronic myelomonocytic leukaemia II2013 | First Faculty of Medicine
- Deletion of the long arm but not the 5q31 region of chromosome 5 in myeloid malignancies2012 | First Faculty of Medicine
- 5-Azacitidine in aggressive myelodysplastic syndromes regulates chromatin structure at PU.1 gene and cell differentiation capacity2012 | First Faculty of Medicine
- Epigenetic silencing of the oncogenic miR-17-92 cluster during PU.1-directed macrophage differentiation2011 | First Faculty of Medicine
- Molecular cytogenetic analysis of chromosome 11 breakpoints in acute myeloid leukemiaPublication without faculty affiliation
- Genomic imbalances in 73 patients with MDS and complex karyotypesPublication without faculty affiliation
- Czech MDS Group experience with azacitidine in treatment of high risk MDS and AML patientsPublication without faculty affiliation
Loading network view...